Stay updated on Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from v3.3.3 to v3.3.4, indicating a frontend version update.
    Difference
    0.1%
    Check dated 2026-01-14T02:10:37.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Georgia as a site. Removed the separate Georgia Locations entry and updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T12:47:22.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:24:17.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1 with no evident changes to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:39:34.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page no longer displays the funding-status notice about government operations; the information that the NIH Clinical Center is open and operating status details has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:54:55.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    No significant changes to the study overview, eligibility criteria, interventions, or results were observed between versions. The page content and structure appear consistent with the study record, including enrollment and key dates.
    Difference
    0.5%
    Check dated 2025-11-03T01:19:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.